| The human complement factor H: functional roles, genetic variations and disease associations SR de Córdoba, J Esparza-Gordillo, EG de Jorge, M Lopez-Trascasa, ... Molecular immunology 41 (4), 355-367, 2004 | 649 | 2004 |
| Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome EG de Jorge, CL Harris, J Esparza-Gordillo, L Carreras, EA Arranz, ... Proceedings of the National Academy of Sciences 104 (1), 240-245, 2007 | 460 | 2007 |
| Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome D Pérez-Caballero, C González-Rubio, ME Gallardo, M Vera, ... The American Journal of Human Genetics 68 (2), 478-484, 2001 | 319 | 2001 |
| Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 J Esparza-Gordillo, EG Jorge, A Buil, LC Berges, M Lopez-Trascasa, ... Human Molecular Genetics 14 (5), 703-712, 2005 | 291 | 2005 |
| Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome P Sánchez-Corral, D Pérez-Caballero, O Huarte, AM Simckes, ... The American Journal of Human Genetics 71 (6), 1285-1295, 2002 | 242 | 2002 |
| Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain O Roche, A Blanch, T Caballero, N Sastre, D Callejo, M López-Trascasa Annals of Allergy, Asthma & Immunology 94 (4), 498-503, 2005 | 232 | 2005 |
| Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation R Martínez-Barricarte, M Heurich, F Valdes-Cañedo, E Vazquez-Martul, ... The Journal of clinical investigation 120 (10), 3702-3712, 2010 | 219 | 2010 |
| Consensus statement on the diagnosis, management, and treatment of Angiodema mediated by Bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical … T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... Journal of Investigational Allergology and Clinical Immunology, 2011 | 205* | 2011 |
| Characterization of complement factor H–related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome C Abarrategui-Garrido, R Martínez-Barricarte, M López-Trascasa, ... Blood 114 (19), 4261-4271, 2009 | 201 | 2009 |
| High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis M Trendelenburg, M Lopez-Trascasa, E Potlukova, S Moll, S Regenass, ... Nephrology Dialysis Transplantation 21 (11), 3115-3121, 2006 | 200 | 2006 |
| High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis M Trendelenburg, M Lopez-Trascasa, E Potlukova, S Moll, S Regenass, ... Nephrology Dialysis Transplantation 21 (11), 3115-3121, 2006 | 200 | 2006 |
| Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H P Sánchez-Corral, C Gonzalez-Rubio, SR de Córdoba, ... Molecular immunology 41 (1), 81-84, 2004 | 187 | 2004 |
| The interactive factor h–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with … RE Saunders, C Abarrategui‐Garrido, V Frémeaux‐Bacchi, ... Human mutation 28 (3), 222-234, 2007 | 177 | 2007 |
| IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. ML Trascasa, J Egido, J Sancho, L Hernando Clinical and experimental immunology 42 (2), 247, 1980 | 147 | 1980 |
| Consensus statement on the diagnosis, management, and treatment of Angiodema mediated by Bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical … T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... Journal of Investigational Allergology and Clinical Immunology, 2011 | 145 | 2011 |
| Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree J Esparza-Gordillo, EG de Jorge, CA Garrido, L Carreras, ... Molecular immunology 43 (11), 1769-1775, 2006 | 134 | 2006 |
| Consensus statement on the diagnosis, management, and treatment of angioedema mediated by Bradykinin. Part. II: treatment, follow-up, and special situations T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... Journal of Investigational Allergology and Clinical Immunology, 2011 | 113 | 2011 |
| Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P C Drouet, A Désormeaux, J Robillard, D Ponard, L Bouillet, L Martin, ... Journal of allergy and clinical immunology 121 (2), 429-433, 2008 | 105 | 2008 |
| Cellular adhesion mediated by factor J, a complement inhibitor: evidence for nucleolin involvement S Larrucea, C González-Rubio, R Cambronero, B Ballou, P Bonay, ... Journal of Biological Chemistry 273 (48), 31718-31725, 1998 | 91 | 1998 |
| Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort O Roche, A Blanch, C Duponchel, G Fontán, M Tosi, M López‐Trascasa Human mutation 26 (2), 135-144, 2005 | 82 | 2005 |
